Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro delays can affect your treatment at several points — from waiting on a dose to arrive, to gaps caused by supply shortages, to the slower digestion the medicine itself produces. Each type has a different cause and a different fix. Mounjaro (tirzepatide) is a prescription-only medicine, so any change to your schedule or dose should go through your prescriber rather than being managed alone. This page explains the main kinds of delays people run into, what the evidence says, and when to ask for clinical advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and deliberately so. One of the core mechanisms behind tirzepatide is delayed gastric emptying: the stomach empties more slowly than usual after a meal, which extends the feeling of fullness and reduces how much you want to eat at the next sitting. This is not a malfunction, it is part of how the medicine achieves its effect on appetite and weight. The detail on tirzepatide and gastric emptying explains the physiology more fully, but the short version is that food simply takes longer to move from your stomach into the small intestine.
For most people this is noticeable mainly in the first few weeks, particularly after dose increases, when nausea and a heavy, overly-full feeling are most common. Those sensations often settle as the body adjusts. Eating smaller portions, avoiding high-fat meals and staying well hydrated all tend to help. If symptoms are persistent or severe, that is a conversation to have with your prescriber rather than something to push through.
One practical knock-on: because the stomach empties more slowly, oral medicines taken at the same time as food may be absorbed differently. The NHS patient information for tirzepatide notes this interaction and recommends telling your prescriber about everything else you take. This matters most for medicines with narrow therapeutic windows, your prescriber is the right person to assess your individual situation.
UK supply of Mounjaro has faced pressures at various points since its launch. Wholesale shortages can mean a specific strength is temporarily unavailable, and that can leave people mid-titration with a gap in their supply. Missing a week occasionally is unlikely to undo meaningful progress, but longer gaps can allow appetite to return and weight to edge back up.
If a particular strength is unavailable, the key question is whether to hold at your current dose, drop back temporarily, or pause treatment altogether, and that decision belongs with your prescriber, not a general rule of thumb. Some people find that ordering ahead of when they need the next pen removes most of the stress. It is worth remembering that couriers and pharmacies have their own rhythms too: ordering around a bank holiday or on a Friday afternoon adds a day or two. Ordering by 12pm on a weekday (Monday tends to be the smoothest) means dispatch the same day once approved.
If you are currently without supply and looking at your options, our guide to the Mounjaro 30-day supply cycle covers how the pen schedule works and what to plan around. For background on the treatment itself, the Mounjaro overview is a good starting point.
This is one of the questions our prescribers hear fairly regularly, and it is a reasonable one. Rapid weight loss of any kind (including the weight loss that happens during tirzepatide treatment) can affect hormone levels enough to shift the timing of a period. That is a well-recognised pattern with significant calorie reduction, not a unique property of this medicine. There is also early clinical interest in whether GLP-1 receptor agonists may have more direct hormonal effects, though the evidence is still developing.
What is confirmed is that if you use oral contraceptives, tirzepatide's effect on gastric emptying can reduce how reliably the pill is absorbed. NHS guidance advises adding a non-oral method of contraception (such as condoms) for the first four weeks of treatment and for four weeks after each dose increase. This is specific to tirzepatide and reflects the gastric-emptying mechanism described above. More detail on this is covered in our pages on Mounjaro and a delayed period and on whether Mounjaro can delay your period.
Pregnancy is not compatible with tirzepatide treatment; neither is breastfeeding or actively trying to conceive. Anyone in those situations should speak with their GP or prescriber before continuing or starting treatment.
A short gap (a day or two either side of your usual injection day) rarely causes clinical problems. The medicine has a long half-life and was studied with weekly dosing, so minor timing drift is expected. However, if a gap stretches beyond two weeks, clinical guidance is to treat the restart more like beginning a new course than simply picking up mid-schedule. Your prescriber will advise on the right dose to resume at rather than jumping straight back to where you were.
Beyond supply gaps, certain symptoms warrant prompt contact: severe stomach pain that radiates towards the back, persistent vomiting that prevents you from keeping fluids down, or signs of a serious allergic reaction. The NHS tirzepatide page lists the full set of symptoms that need urgent attention. For anything that feels serious, NHS 111 or your GP surgery is the right route. You can also report unexpected symptoms directly through the MHRA Yellow Card scheme, which helps regulators monitor emerging patterns with newer medicines.
If you are managing an ongoing course and want clinical support available seven days a week, starting a free consultation with nume connects you with a GPhC-registered prescriber who reviews each case personally. Cost context, including what private treatment typically includes, is set out on the Mounjaro prices page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.